176 related articles for article (PubMed ID: 35711002)
1. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
Zhou M; Han S; Zhang W; Wu D
J Bone Miner Metab; 2022 Sep; 40(5):763-772. PubMed ID: 35711002
[TBL] [Abstract][Full Text] [Related]
2. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW
Osteoporos Int; 2015 Mar; 26(3):1175-86. PubMed ID: 25516361
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials.
Ma ML; Ma ZJ; He YL; Sun H; Yang B; Ruan BJ; Zhan WD; Li SX; Dong H; Wang YX
Front Public Health; 2022; 10():979649. PubMed ID: 36033779
[TBL] [Abstract][Full Text] [Related]
4. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
Su S; He N; Men P; Song C; Zhai S
Osteoporos Int; 2019 Jun; 30(6):1175-1186. PubMed ID: 30734066
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia.
Purwosunu Y; Muharram ; Rachman IA; Reksoprodjo S; Sekizawa A
J Obstet Gynaecol Res; 2006 Apr; 32(2):230-4. PubMed ID: 16594930
[TBL] [Abstract][Full Text] [Related]
7. Role of vitamin K2 in the treatment of postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Drug Saf; 2006 Jan; 1(1):87-97. PubMed ID: 18690918
[TBL] [Abstract][Full Text] [Related]
8. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
[TBL] [Abstract][Full Text] [Related]
9. Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis.
Kasukawa Y; Miyakoshi N; Ebina T; Aizawa T; Hongo M; Nozaka K; Ishikawa Y; Saito H; Chida S; Shimada Y
J Bone Miner Metab; 2014 May; 32(3):290-7. PubMed ID: 23846118
[TBL] [Abstract][Full Text] [Related]
10. Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Liu C; Kuang X; Li K; Guo X; Deng Q; Li D
Food Funct; 2020 Dec; 11(12):10817-10827. PubMed ID: 33237064
[TBL] [Abstract][Full Text] [Related]
11. Vitamin K₂ therapy for postmenopausal osteoporosis.
Iwamoto J
Nutrients; 2014 May; 6(5):1971-80. PubMed ID: 24841104
[TBL] [Abstract][Full Text] [Related]
12. Blosozumab in the treatment of postmenopausal women with osteoporosis: a systematic review and meta-analysis.
Su Y; Wang W; Liu F; Cai Y; Li N; Li H; Li G; Ma L
Ann Palliat Med; 2022 Oct; 11(10):3203-3212. PubMed ID: 36367007
[TBL] [Abstract][Full Text] [Related]
13. Effects of vitamin K in postmenopausal women: mini review.
Guralp O; Erel CT
Maturitas; 2014 Mar; 77(3):294-9. PubMed ID: 24342502
[TBL] [Abstract][Full Text] [Related]
14. Comparison of concurrent treatment with vitamin K
Tanaka S; Miyazaki T; Uemura Y; Miyakawa N; Gorai I; Nakamura T; Fukunaga M; Ohashi Y; Ohta H; Mori S; Hagino H; Hosoi T; Sugimoto T; Itoi E; Orimo H; Shiraki M
J Bone Miner Metab; 2017 Jul; 35(4):385-395. PubMed ID: 27484436
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
16. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
Rønn SH; Harsløf T; Oei L; Pedersen SB; Langdahl BL
Osteoporos Int; 2021 Jan; 32(1):185-191. PubMed ID: 33030563
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with vitamin k2 and bisphosphonate in postmenopausal women with osteoporosis.
Iwamoto J; Takeda T; Ichimura S
Yonsei Med J; 2003 Oct; 44(5):751-6. PubMed ID: 14584089
[TBL] [Abstract][Full Text] [Related]
18. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E
Osteoporos Int; 2013 Sep; 24(9):2499-507. PubMed ID: 23525894
[TBL] [Abstract][Full Text] [Related]
19. Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial.
Jiang Y; Zhang ZL; Zhang ZL; Zhu HM; Wu YY; Cheng Q; Wu FL; Xing XP; Liu JL; Yu W; Meng XW
Clin Interv Aging; 2014; 9():121-7. PubMed ID: 24426779
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.
Emaus N; Gjesdal CG; Almås B; Christensen M; Grimsgaard AS; Berntsen GK; Salomonsen L; Fønnebø V
Osteoporos Int; 2010 Oct; 21(10):1731-40. PubMed ID: 19937427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
